Narrow your search

Library

ULiège (10)

ULB (9)

KU Leuven (5)

Odisee (4)

Thomas More Kempen (4)

Thomas More Mechelen (4)

UCLL (4)

UGent (4)

VIVES (4)

EhB (1)

More...

Resource type

book (13)

dissertation (1)


Language

English (12)

French (2)


Year
From To Submit

2020 (1)

2019 (1)

2014 (1)

2013 (1)

2012 (3)

More...
Listing 1 - 10 of 14 << page
of 2
>>
Sort by

Dissertation
Eligibilité au traitement antiviral des détenus infectés par le virus de l'hépatite C en région liégeoise
Author:
Year: 2011 Publisher: [S.l.] : [chez l'auteur],

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Guidelines for the screening, care and treatment of persons with hepatitis C infection : April 14
Authors: ---
ISBN: 9241548754 9240693904 Year: 2014 Publisher: Geneva, Switzerland : World Health Organization,

Loading...
Export citation

Choose an application

Bookmark

Abstract

These are the first WHO guidelines on the screening care and treatment ofpersons with HCV infection. They are intended to complement existing guidanceon the primary prevention of HCV and other bloodborne viruses by improvingblood and injection safety and health care for people who inject drugs (PWID)and other vulnerable groups including those living with HIV (see section 2.4 forrelated WHO guidelines).These guidelines are primarily targeted at policy-makers in ministries of healthworking in low- and middle-income countries who formulate country-specifictreatment guidelines and who plan infe


Book
Management of hepatitis C : 2002 : January 1997 through April 2002 : 4,841 citations
Authors: --- --- ---
Year: 2002 Publisher: Bethesda, Md. (8600 Rockville Pike) : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Management of hepatitis C : 2002 : January 1997 through April 2002 : 4,841 citations
Authors: --- --- ---
Year: 2002 Publisher: Bethesda, Md. (8600 Rockville Pike) : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine, Reference Section,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Requiem pour un virus : une brève histoire de l'hépatite C
Authors: ---
ISBN: 9782746753761 Year: 2019 Publisher: Paris : Autrement,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Milieu des années 1970. Une maladie du foie inconnue fait son apparition, probablement virale, qui n'est ni une hépatite A, ni une hépatite B. D'abord jugés bénins, les symptômes se font vite inquiétants. Malgré tous les efforts de la communauté médicale et scientifique mondiale, le virus demeure invisible et se propage... Quarante ans plus tard, démasqué, il vit ses derniers moments. Aujourd'hui, l'hépatite C peut être guérie à presque cent pour cent. Des patients qui ont souffert de la maladie aux médecins et aux scientifiques qui l'ont vaincue, cet ouvrage met en scène les principaux acteurs de cette fulgurante histoire. Un peu moins de cent mille malades restent à soigner en France. Après cette ultime bataille, la dernière heure de l'hépatite C aura enfin sonné dans l'Hexagone. Et bientôt partout dans le monde ? (source : 4e de couverture)

Hepatitis C viruses : genomes and molecular biology
Author:
ISBN: 1904933203 Year: 2006 Publisher: [Place of publication not identified] Horizon Bioscience


Book
Chronic hepatitis C virus : advances in treatment, promise for the future
Author:
ISBN: 9781461411925 9781461411918 Year: 2012 Publisher: New York : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future documents the monumental advances that have been made in our understanding of chronic HCV during the past decade. The first section reviews the natural history of chronic HCV, how this virus can affect other organs in addition to the liver, and whether treating chronic HCV alters the natural history of this disease. Section 2 reviews the advances that have been made in the treatment of chronic HCV during the past decade with interferon based therapy. Separate chapters on response guided therapy and how to manage the adverse events associated with these medications provide the physician with the concepts required to more effectively treat chronic HCV now and in the future. As the genetics of virologic response have recently been elucidated, a chapter is devoted to helping the clinician understand how genes that modulate disease processes and their treatment are identified and utilized in clinical care. Section 3 deals with the future of HCV treatment and specific inhibitors of HCV. Specific chapters explain how targets for drugs are identified and how drugs are then developed and tested; how mutations of HCV develop and how anti-viral agents will affect this process; the most up to date data regarding the treatment of chronic HCV with peginterferon, ribavirin and anti-viral agents; and the potential to treat chronic HCV with just oral anti-viral agents and without peginterferon and ribavirin in the future. The final section of this book covers issues related to liver transplantation in patients with chronic HCV. Separate chapters review the natural history of chronic HCV in liver transplant recipients and the impact of utilizing HCV positive donors. The volume concludes with chapters that cover the treatment of chronic HCV both prior to and after liver transplantation with potent anti-viral agents. Chronic Hepatitis C Virus: Advances in Treatment, Promise for the Future is a valuable resource for all physicians caring for patients with chronic HCV.


Book
Equine Viruses
Author:
ISBN: 3039283219 3039283200 Year: 2020 Publisher: MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

The Food and Agriculture Organization of the United Nations has recently estimated that the world equid population exceeds 110 million. Working equids (horses, ponies, donkeys, and mules) remain essential to ensure the livelihood of poor communities around the world. In many developed countries, the equine industry has significant economical weight, with around 7 million horses in Europe alone. The close relationship between humans and equids and the fact that the athlete horse is the terrestrial mammal that travels the most worldwide after humans are important elements to consider in the transmission of pathogens and diseases, amongst equids and to other species. The potential effect of climate change on vector ecology and vector-borne diseases is also of concern for both human and animal health. In this Special Issue, we intend to explore our understanding of a panel of equine viruses, looking at their pathogenicity, their importance in terms of welfare and potential association with diseases, their economic importance and impact on performance, and how their identification can be helped by new technologies and methods.


Book
Hepatitis C virus : from molecular virology to antiviral therapy
Author:
ISBN: 3642273394 364242936X 3642273408 Year: 2013 Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Hepatitis C virus (HCV), a major causative agent of chronic liver disease, is spread throughout the world and around 170 million people are persistently infected. In this volume, world-leading experts in the field of HCV research have compiled the most recent scientific advances to provide a comprehensive and very timely overview of the various facets of HCV. The book starts with a discussion of the possible origin of HCV and its spread among the human population. The focus of the subsequent chapters is on available cell culture and in vivo models before shifting to the molecular and cellular principles underlying the viral replication cycle. These chapters are complemented by insightful descriptions of the innate and adaptive immune responses to HCV as well as the virus-associated pathogenesis. Finally, the development of antiviral therapies, which is closely linked with progress in basic research, and the implementation of those therapies into present and future daily clinical practice are highlighted.

Listing 1 - 10 of 14 << page
of 2
>>
Sort by